However, NLY01, a brain-penetrant, pegylated, longer-lasting version of exenatide, provided no significant benefits in PD patients with a H&Y stage of 2.5 and an average disease duration of 1 year, as assessed by the MDS-UPDRS Parts II and III scores
Nasal sprays are often preferred for their non-invasive nature and simplicity, improving participant compliance and the practicality of long-term studies
If you take these combinations, your GP may advise increased blood glucose monitoring and possible dose reduction of insulin or sulphonylureas
GIP (114) is a partial agonist of GIPR
Hypoglycaemia: Risk is low when used alone but increases if combined with insulin or sulfonylureas (for example, gliclazide or glibenclamide)
If you're concerned about muscle loss, schedule a consultation to discuss your specific protein needs and eating strategy